Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Paula Muñiz
Observed names:
Muñiz, P.,
P. Muñiz,
P. Muñíz,
Paula Muñiz Sevilla
Institutions:
Hospital Universitario La Paz,
Hospital General Universitario Gregorio Marañón,
Hospital La Paz Institute for Health Research,
Instituto de Investigación Sanitaria Gregorio Marañón
Observed institutions:
Hospital Universitario La Paz,
Hospital General Universitario Gregorio Marañón,
Hospital La Paz Institute for Health Research,
Instituto de Investigación Sanitaria Gregorio Marañón,
Universidad Carlos III de Madrid
ORCID:
0000-0002-8252-3459
Observed ORCID:
0000-0002-8252-3459
OpenAlex ID:
A5031853703
Next-Generation Sequencing Improves Diagnosis, Prognosis and Clinical Management of Myeloid Neoplasms
2019
·
Diego Carbonell
, Julia Suárez-González
, et al.
·
Cancers
·
40
PDF
Short Tandem Repeats (STRs) as Biomarkers for the Quantitative Follow-Up of Chimerism after Stem Cell Transplantation: Methodological Considerations and Clinical Application
2020
·
Almudena Navarro-Bailón
, Diego Carbonell
, et al.
·
Genes
·
38
PDF
Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation
2022
·
Paula Muñiz
, Cristina Andrés-Zayas
, et al.
·
Frontiers in Immunology
·
30
EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment
2022
·
C. Martínez-Laperche
, L. Sanz-Villanueva
, et al.
·
BMC Cancer
·
27
PDF
Clinical Utility of the Detection of the Loss of the Mismatched HLA in Relapsed Hematological Patients After Haploidentical Stem Cell Transplantation With High-Dose Cyclophosphamide
2021
·
Paula Muñiz
, Mi Kwon
, et al.
·
Frontiers in Immunology
·
19
PDF
Elafin as a Predictive Biomarker of Acute Skin Graft-Versus-Host Disease After Haploidentical Stem Cell Transplantation Using Post-Transplant High-Dose Cyclophosphamide
2021
·
Laura Solán
, Diego Carbonell
, et al.
·
Frontiers in Immunology
·
19
PDF
Digital PCR Improves Sensitivity and Quantification in Monitoring CAR-T Cells in B Cell Lymphoma Patients
2024
·
Ismael de la Iglesia-San Sebastián
, Diego Carbonell
, et al.
·
Transplantation and Cellular Therapy
·
15
Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms
2022
·
Miren Vallejo
, Paula Muñiz
, et al.
·
Annals of Hematology
·
13
PDF
Incorporation of next-generation sequencing in clinical practice using solid and liquid biopsy for patients with non-Hodgkin’s lymphoma
2021
·
Mariana Bastos-Oreiro
, Julia Suárez-González
, et al.
·
Scientific Reports
·
12
PDF
Clinical utility of targeted next‐generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition
2021
·
Cristina Andrés‐Zayas
, Julia Suárez‐González
, et al.
·
Molecular Oncology
·
8
PDF
Cell-Free DNA Dynamic Concentration and Other Variables Are Predictors of Early Progression after Chimeric Antigen Receptor T Cell Therapy in Patients with Diffuse Large B Cell Lymphoma
2023
·
Mariana Bastos-Oreiro
, Laura Sanz-Villanueva
, et al.
·
Transplantation and Cellular Therapy
·
7
Next Generation Cytogenetics in Myeloid Hematological Neoplasms: Detection of CNVs and Translocations
2021
·
María Chicano
, Diego Carbonell
, et al.
·
Cancers
·
7
PDF
FLT3-ITD Expression as a Potential Biomarker for the Assessment of Treatment Response in Patients with Acute Myeloid Leukemia
2022
·
Diego Carbonell
, María Chicano
, et al.
·
Cancers
·
6
PDF
Identification of predictive models including polymorphisms in cytokines genes and clinical variables associated with post-transplant complications after identical HLA-allogeneic stem cell transplantation
2024
·
Paula Muñiz
, María Martínez-García
, et al.
·
Frontiers in Immunology
·
2
PDF
Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment
2022
·
C. Martínez-Laperche
, L. Sanz-Villanueva
, et al.
·
BMC Cancer
·
2
PDF
Genetic biomarkers identify a subgroup of high-risk patients within low-risk NPM1-mutated acute myeloid leukemia
2020
·
Diego Carbonell
, Julia Suárez-González
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
2
Novel Candidate loci and Pathogenic Germline Variants Involved in Familial Hematological Malignancies Revealed by Whole-Exome Sequencing
2023
·
Cristina Andrés-Zayas
, Julia Suárez-González
, et al.
·
Cancers
·
1
PDF
Association of Gene Polymorphisms in Cyclophosphamide Metabolism Pathway with Complications after Haploidentical Hematopoietic Stem Cell Transplantation
2020
·
Paula Muñiz Sevilla
, Cristina Andres
, et al.
·
Blood
·
1
EZH2 mutation status predicts inferior outcomes after bendamustine‐based immunochemotherapy in frontline follicular lymphoma: A GELTAMO multicenter validation study
2026
·
Carolina Martínez‐Laperche
, Pilar Lancho‐Lavilla
, et al.
·
HemaSphere
PDF
P329 - ECE_1941 - Role of the FGF signaling pathway in the etiopathogenesis of congenital hypogonadotropic hypogonadism
2026
·
Rosa García Moreno
, Patricia Martín Rojas-Marcos
, et al.
·
European Journal of Endocrinology
Personalized Monitoring of Circulating Tumor DNA By a Specific Signature of Trackable Mutations after Chimeric Antigen Receptor t-Cell Therapy in Non-Hodgkin B Cell Lymphoma
2023
·
Santiago Barrio
, Carolina Martinez-Laperche
, et al.
·
Blood
Personalized monitoring of circulating tumor DNA by a specific signature of trackable mutations after chimeric antigen receptor t‐cell therapy in non‐Hodgkin B cell lymphoma
2023
·
M. Bastos
, S. Barrio
, et al.
·
Hematological Oncology
PDF
Identification of Predictive Models Including Polymorphisms in Cytokines Genes Associated with Post-Transplant Complications after Identical HLA-Allogeneic Stem Cell Transplantation
2022
·
Paula Muñiz Sevilla
, María Martínez-García
, et al.
·
Blood
P1427: Monitoring Car-t Cell in B-cell Lymphoma Patients Through Single Chain Variable Fragment by Digital Pcr
2022
·
I. De La Iglesia San Sebastián
, D. Carbonell
, et al.
·
HemaSphere
P391: Flt3-itd Measurement at Diagnosis and for the Assessment of Minimal Residual Disease After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia: Cdna Vs. Dna
2022
·
D. Carbonell
, M. Chicano
, et al.
·
HemaSphere
Show more works
View as search
Works count:
33
Citation count:
249
H-index:
9
I10-index:
9
Year
Topic
Type